Fournier J, Boussat B, Dervaux B, Gaudin P, et al. Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. Clin Exp Rheumatol 2024 Oct 3. doi: 10.55563.
PMID: 39360378